Skip to main content

FDA warns hydroxychloroquine may weaken effectiveness of coronavirus drug remdesivir

The Food and Drug Administration warned that taking anti-malaria drug hydroxychloroquine along with antiviral drug remdesivir "may result in reduced antiviral activity" of the latter.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.